Talon Therapeutics, Inc. 4
4 · Talon Therapeutics, Inc. · Filed Jul 18, 2013
Insider Transaction Report
Form 4
Gharib Samir M.
Interim Controller
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2013-07-17−75,000→ 0 totalExercise: $0.48Exp: 2022-01-09→ Common Stock (75,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−50,000→ 0 totalExercise: $0.64Exp: 2023-01-25→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This stock option was cancelled pursuant to the terms of a Stock Purchase Agreement by and among Talon Therapeutics, Inc., Spectrum Pharmaceuticals, Inc. and Eagle Acquisition Merger Sub, Inc. dated July 16, 2013.